[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 3, Issue 1 (Int J Mol Cell Med 2014) ::
Int J Mol Cell Med 2014, 3(1): 26-34 Back to browse issues page
Evaluation of pre-treatment serum levels of IL-7 and GM-CSF in colorectal cancer patients
Mehdi Taghipour Fard Ardekani1, Mahyar Malekzadeh1, Mohammad Vahid Hosseini2, Elahe Bordbar1, Zahra Mojtahei1, Mehrnoosh Doroudchi 3, Abbas Ghaderi1
1- Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
2- Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
3- Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. , mdoroud@sums.ac.ir
Abstract:   (8132 Views)
Background: Survival of Colorectal cancer (CRC) patients is considerably stage-dependent therefore, early diagnosis is a pivotal factor in decreasing mortality and morbidity associated with this cancer. GM-CSF and IL-7 are reported to increase in different cancers and we aim to investigate the pre-treatment serum levels of GM-CSF and IL-7 in Iranian patients with colorectal cancer. Methods: 127 patients (68 males and 59 females) before receiving chemotherapy or radiotherapy entered to this study. A control group of 50 healthy age/sex matched individuals (27 males and 23 females) were included in the study. Serum levels of GM-CSF and IL-7 were measured using commercial enzyme linked immunosorbent assays. Results: A significantly higher level of GM-CSF was found in the sera of patients with colorectal cancer compared with healthy age/sex matched controls (p=0.013). However, there was no significant difference between the levels of IL-7 in sera of patients and controls. We observed a significant elevation in the level of GM-CSF in poorly differentiated tumors (p=0.024). Also a significant correlation between lymphatic invasion and the level of GM-CSF in sera of CRC patients was detected (p=0.01). We found an increase in the level of IL-7 in the three patients in the moderate stages of the tumor concomitant with a decrease in the level of GM-CSF. Conclusion: Increase in the level of GM-CSF is accompanied by CRC progression in Iranian patients, while there may be a potential therapeutic effect of IL-7 in this disease.
Keywords: Colorectal cancer, Serum, GM-CSF, IL-7
Full-Text [PDF 141 kb]   (2158 Downloads)    
Type of Study: Original Article | Subject: Cancer
Received: 2013/10/17 | Accepted: 2013/12/15 | Published: 2013/12/25
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Taghipour Fard Ardekani M, Malekzadeh M, Vahid Hosseini M, Bordbar E, Mojtahei Z, Doroudchi M et al . Evaluation of pre-treatment serum levels of IL-7 and GM-CSF in colorectal cancer patients. Int J Mol Cell Med. 2014; 3 (1) :26-34
URL: http://ijmcmed.org/article-1-112-en.html


Volume 3, Issue 1 (Int J Mol Cell Med 2014) Back to browse issues page
International Journal of Molecular and Cellular Medicine (IJMCM) International Journal of Molecular and Cellular Medicine (IJMCM)
Persian site map - English site map - Created in 0.05 seconds with 32 queries by YEKTAWEB 4162